Involvement of VIP Signaling in Right Cardiac Hypertrophy
Project/Area Number |
21591981
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Anesthesiology/Resuscitation studies
|
Research Institution | Yokohama City University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
MIZUNO Yusuke 横浜市立大学, 医学部, 講師 (80433192)
KAWAKAMI Hiromasa 横浜市立大学, 医学部, 助教 (90407958)
|
Project Period (FY) |
2009 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2010: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2009: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
|
Keywords | 右心肥大 / PACAP/VIP / 心臓神経叢 / 遺伝子治療 / レンチウイルス / 心肥大 / VIP / PACAP / プラスミドベクター |
Research Abstract |
Elevated PACAP but not VIP signaling was associated with right ventricular hypertrophy and heart failure induced with monocrotaline in rats. PACAP-preferring receptor PCAl and the common receptor VPAC2 were up-regulated in both ventricles. Thus, PACAP signaling may play a more predominant role during cardiac hypertrophy and hear failure.
|
Report
(4 results)
Research Products
(7 results)